The anthrax vaccine market is expected to register an estimated CAGR of 7.6% during the forecast period.
The anthrax vaccine market is consolidated with a few market players in the human and animal segments. In terms of market share, major players dominate the market. With the rising prevalence of disease and increasing awareness among the public, many new players may enter the market over the forecast period. Some market players are Emergent Bio Solutions Inc., Altimmune (Pharmathene Inc.), Proton Biopharma Ltd., Colorado Serum Company, Bayer AG, and Merck & Co. Inc.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook